美国DVS Sciences  
DVS Sciences, Inc. 生产并在全球分销新型生物分析解决方案，这些解决方案用于生物标记物的发现、生物学研究，将来也可能用于临床。已获专利保护的多参数技术包括一台用于单个细胞定量分析的高通量大量细胞计数仪、CyTOF和一套试剂，其中包含稳态同位素标记的抗体。CyTOF平台克服了传统流式血细胞计数的局限性，简化了样本制备，最多能同时检测100种生物标记物，分辨率高、动态范围宽。CyTOF系统已安装于美国、加拿大、欧洲和亚洲的领先实验室。DVS Sciences的全球总部和试剂盒生产设在加州Sunnyvale，研发和仪器生产设在加拿大多伦多附近，销售/支持办事处设在英国。

DVS Sciences Inc. is an analytical equipment and reagents development company that produces and markets the:

CyTOF® instrument - a high throughput mass cytometer for individual cell analysis based on a novel elemental mass-spectrometry detection technology
MAXPAR® system of reagents related to massively multi-parametric assays.
Both of the DVS Sciences™ brands of CyTOF and MAXPAR technology are covered by company patents.

With over 20 years of proven innovation in atomic spectroscopy, the Founders of DVS Sciences Inc., conceived and patented the technology while working at MDS Sciex with its joint venture partner PerkinElmer Health Sciences, Inc.

In 2005, the Founders continued their innovation and further developed the CyTOF and MAXPAR technology portfolio at the University of Toronto in collaboration with researchers and academic leaders in multidisciplinary fields. Continuing the evolution from the own facilities, DVS Sciences Inc. now owns and licenses over 50 Patents and Patent Applications throughout the world including its exclusive licenses from PerkinElmer and the University of Toronto.

DVS Science Inc. is committed to developing robust, innovative instrumentation, reagents and consumables that accelerate medical research and transform drug discovery via highly multiplexed bio-analysis.